In a significant development the European Union has filed a complaint with the World Trade Organization against China saying that Chinese courts were preventing European companies from protecting their telecom technology patents. The European Commission filed the challenge on behalf… Read More ›
patents
Pfizer’s surge in revenue triggers potential acquisitions
On Tuesday, investors hope to learn Pfizer Inc’s plans for what could be a once in a generation cash infusion from COVID-19 treatments and vaccines in 2022. Some drugmakers are looking to spend on potential acquisitions. According to Chief Executive Albert… Read More ›
SK Innovation did not violate LG Energy Solution battery related patents: U.S. International Trade Commission
In a significant development for South Korea’s SK Innovation Co Ltd, the U.S. International Trade Commission (ITC) has ruled that the South Korean battery company did not violate LG Energy Solution’s battery-related patents. The initial determination by the ITC marks… Read More ›
U.S. approach to industry-standard patents undergoes policy-shift
In a far-reaching policy shift, officials from the United States antitrust and patent office stated they no longer deem holders of industry-standard patents anti-competitive if they sue to stop the sale of infringing products. In a joint statement, the U.S…. Read More ›
Huawei hogs limelight in opening of lawsuit in Sherman, Texas
The lawsuit is the first to be heard under the U.S. Defend Trade Secrets Act of 2016; as per Matthew Goss, general counsel for CNEX, Huawei is “weaponizing our courts against U.S. companies.” On Monday, in a lawsuit that is… Read More ›
Monsanto wins court battle in India for its GM cotton seeds
The ruling from India’s highest court assumes significance since India is the world’s No. 1 cotton producer. On Tuesday, India’s Supreme Court ruled in favor of Monsanto and allowed it to claim patents on its genetically modified cotton seeds, said… Read More ›
Pfizer Inc’s CEO Ian Read to also become its executive chairman in Jan 2019
The strategic development places the Ian Read as its chairman and opens up the CEO post which could be filled at a later date. Under Read’s steady stewardship, Pfizer Inc’s stock has gone up by 160% since December 2010. Pfizer… Read More ›
Qualcomm eases licensing terms, to unclog inflow of revenues
Through this strategic move Qualcomm is aiming to avoid potental future legal disputes and maintain its existing business structure. In a development that underscores how far Qualcomm Inc is willing to go to preserve its core business practice of making… Read More ›
Landmark Transfer Pricing tax suit – Coca-Cola vs the U.S. IRS
The lawsuit is drawing loads of eyeballs since it could set a precedent for MNCs over their transfer pricing mechanism. In a lawsuit, closely watched by tax experts, that marks a growing signs of tension between the U.S. Internal Revenue… Read More ›
A brief outlook on the impact of the U.S. tax code on Apple Inc
Analysts opine, the revised repatriation rules are likely to be the pivot in Apple’s cash strategy. With the U.S. Congress passing the Republican-led tax overhaul bill, one of Apple’s long standing goal of repatriating $252.3 billion in foreign cash without… Read More ›